| Product Code: ETC13341120 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East mRNA Vaccines and Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East mRNA Vaccines and Therapeutics Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Middle East mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.8 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.10 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Middle East mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East mRNA Vaccines and Therapeutics Market Trends |
6 Middle East mRNA Vaccines and Therapeutics Market, 2021 - 2031 |
6.1 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031 |
6.1.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Influenza Vaccine, 2021 - 2031 |
6.1.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Rabies Vaccine, 2021 - 2031 |
6.1.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Zika Virus Vaccine, 2020 - 2028 |
6.1.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By CMV Vaccine, 2020 - 2028 |
6.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031 |
6.2.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031 |
6.2.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031 |
6.2.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031 |
6.2.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By mRNA-Based Drug Delivery, 2020 - 2028 |
6.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.3.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.3.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intramuscular Injection, 2021 - 2031 |
6.4.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Subcutaneous Injection, 2021 - 2031 |
6.4.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intradermal Injection, 2020 - 2028 |
6.4.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Intravenous Infusion, 2020 - 2028 |
6.4.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Oral Delivery, 2020 - 2028 |
6.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Hospitals, 2020 - 2028 |
6.5.3 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Clinics, 2020 - 2028 |
6.5.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.5.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Biotechnology Firms, 2020 - 2028 |
6.5.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Pharmaceutical Companies, 2020 - 2028 |
7 Middle East mRNA Vaccines and Therapeutics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 Saudi Arabia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 UAE mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Kuwait mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Qatar mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.5 Bahrain mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.6 Oman mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.7 Turkey mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.8 Rest of Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Middle East mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
7.3.1 Saudi Arabia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.2 UAE mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.3 Kuwait mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.4 Qatar mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.5 Bahrain mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.6 Oman mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.7 Turkey mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.3.8 Rest of Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Therapeutic Type, 2021 - 2031 |
7.4 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 Saudi Arabia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 UAE mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Kuwait mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Qatar mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.5 Bahrain mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.6 Oman mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.7 Turkey mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.8 Rest of Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.1 Saudi Arabia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.2 UAE mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.3 Kuwait mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.4 Qatar mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.5 Bahrain mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.6 Oman mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.7 Turkey mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.5.8 Rest of Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By Delivery Method, 2021 - 2031 |
7.6 Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.1 Saudi Arabia mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.2 UAE mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.3 Kuwait mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.4 Qatar mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.5 Bahrain mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.6 Oman mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.7 Turkey mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
7.6.8 Rest of Middle East mRNA Vaccines and Therapeutics Market, Revenues & Volume, By End User, 2020 - 2028 |
8 Middle East mRNA Vaccines and Therapeutics Market Key Performance Indicators |
9 Middle East mRNA Vaccines and Therapeutics Market - Export/Import By Countries Assessment |
10 Middle East mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
10.1 Middle East mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Middle East mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
10.4 Middle East mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Middle East mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
10.6 Middle East mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Middle East mRNA Vaccines and Therapeutics Market - Competitive Landscape |
11.1 Middle East mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2022 |
11.2 Middle East mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here